Summary: Managing angina is fundamentally about balancing oxygen supply and demand. By using Vesugen and BPC-157 to physically increase blood flow through improved vessel elasticity and new capillary growth, and Cheluhart to improve the heart's metabolic efficiency, you attack the problem from both sides. This protocol offers a pathway to a more active, pain-free life by improving the fundamental perfusion and function of the heart muscle.
While standard medications like nitroglycerin pills can open arteries temporarily to abort an attack, and beta-blockers slow the heart to reduce its need for oxygen, they do not fix the underlying supply issue. A peptide protocol for angina focuses on perfusion —permanently increasing the amount of blood that can reach the heart muscle. By stimulating the growth of new micro-vessels and improving the metabolic efficiency of the heart cells, we can raise the “ischemic threshold,” allowing you to walk, climb stairs, and live your life without the constant fear of that sudden chest tightness.
The Micro-Circulation Booster: Vesugen + BPC-157
To solve the supply problem, we need better plumbing. We use a synergistic combination of Vesugen (the vascular bioregulator) and BPC-157.
- Vesugen works on the macro-level. It penetrates the endothelial cells of the larger coronary arteries and stimulates protein synthesis, restoring their elasticity. This helps the arteries dilate (widen) more effectively and responsively when you begin to exercise, allowing more blood to flow when it is needed most.
- BPC-157 works on the micro-level. It stimulates angiogenesis in the heart muscle itself, creating a denser network of capillaries and collateral vessels. This means that even if a main coronary artery is partially narrowed by plaque, the blood has more alternate routes (“collateral circulation”) to reach the thirsty muscle cells. This re-vascularization directly reduces the frequency and severity of angina episodes by ensuring the tissue gets fed.
The Metabolic Optimizer: Cheluhart
Sometimes, due to severe disease, we can’t get significantly more blood to the heart immediately. In these cases, we must make the heart more efficient with the limited blood it has. Cheluhart (heart muscle bioregulator) is the key agent here.
- Mechanism: Cheluhart acts directly on the cardiomyocytes to improve their metabolic function. It upregulates the genes responsible for energy production and contraction. This helps the heart generate the same pumping force using less oxygen—essentially improving the “gas mileage” of the heart.
- Benefit: This increased metabolic efficiency means the heart is less likely to hit that “oxygen debt” wall that triggers the pain signal. Patients often report they can perform more physical activity (increased exercise tolerance) before feeling the onset of symptoms. It stabilizes the heart cell membrane, making it more resistant to the stress of ischemia.
